2C12.0Y

ICD-11 MMS 2026-01

Other specified malignant neoplasm of liver

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Exclusions from above levels

  • 2C17 – Malignant neoplasm of biliary tract NOS
  • 2D80 – Secondary malignant neoplasm of liver
  • http://id.who.int/icd/entity/111033337 – Malignant neoplasm metastasis in digestive system
Show allHide
  • http://id.who.int/icd/entity/1965082709 – Malignant mesenchymal neoplasms
  • http://id.who.int/icd/entity/794095161 – Malignant neoplasms of lip, oral cavity or pharynx
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Sibling codes

  • 2C12.00 – Combined hepatocellular-cholangiocarcinoma
  • 2C12.01 – Hepatoblastoma
  • 2C12.02 – Hepatocellular carcinoma of liver
  • 2C12.03 – Mesothelial carcinoma of liver
  • 2C12.0Z – Malignant neoplasm of liver, unspecified

Foundation entity

Malignant neoplasm of liver – http://id.who.int/icd/entity/1605020868

Allowed postcoordination axes

Part of: 2C12.0: Malignant neoplasm of liver › 2C12: Malignant neoplasms of liver or intrahepatic bile ducts › 02: Neoplasms